Vice President, Immunology Unit - Commercial | Additional Leadership Roles
Raleigh-Durham, North Carolina Area
VP, Immunology Unit - US Commercial 2009 – 2010Built and led new business unit dedicated to commercialization of biopharmaceuticals, a new priority for corporate’s global strategic plan with a target of $3.2 billion by 2020. Reported to President, US Commercial.VP, HIV - US Commercial 2001 – 2009Full P&L responsibility for autonomous HIV division with $1.6 billion sales. Managed a staff of 140 and a $75 million sales and marketing budget. Reported to President, US Commercial.VP, R&D Product Development - GlaxoWellcome 1999 – 2001Global leadership of new product development division in metabolic, cardiovascular, and oncology that included commercial and medical teams responsible for Phase IIb through to launch. Managed a staff of 80 across US | UK and a clinical development budget of $220 million.VP, R&D Product Development - Oncology | stroke product development 1998 – 1999 Regional Business Director - $200 million P&L responsibility for regional business 1995 – 1998Director of Respiratory Marketing - Leadership for $450 million respiratory franchise 1994 – 1995International Product Management – Directed Zantac patent expiration strategy 1992 – 1994Director of Sales & Marketing, Glaxo Australia - Enabling Zantac to become #1 product 1987 – 1992 Group Product Manager, Respiratory Products, Sales Training and Field Sales 1981 – 1987Glaxo Holdings Accelerated Development Intake 1979 –1981